Detalles de la búsqueda
1.
Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead.
Clin Infect Dis
; 71(Suppl 2): S141-S150, 2020 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725225
2.
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.
BMC Pediatr
; 20(1): 480, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059607
3.
Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
Clin Infect Dis
; 68(Suppl 1): S22-S26, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30767002
4.
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018.
Clin Infect Dis
; 69(Suppl 6): S499-S509, 2019 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665782
5.
Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
Microb Pathog
; 97: 19-26, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27216239
6.
The Need for an Information Communication and Advocacy Strategy to Guide a Research Agenda to Address Burden of Invasive Nontyphoidal Salmonella Infections in Africa.
Clin Infect Dis
; 61 Suppl 4: S380-5, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449955
7.
Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013.
MMWR Morb Mortal Wkly Rep
; 63(39): 855-60, 2014 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25275329
8.
Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis.
PLoS Negl Trop Dis
; 18(4): e0012075, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38574163
9.
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.
Lancet Infect Dis
; 24(5): 488-503, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342105
10.
A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity.
Trop Dis Travel Med Vaccines
; 10(1): 3, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297337
11.
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.
Hum Vaccin Immunother
; 20(1): 2301631, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189360
12.
Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan.
J Health Commun
; 18(3): 306-24, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23330632
13.
Safety and Protective Effects of Influenza Vaccination in Pregnant Women on Pregnancy and Birth Outcomes in Pune, India: A Cross-Sectional Study.
Vaccines (Basel)
; 11(6)2023 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376423
14.
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.
Hum Vaccin Immunother
; 19(1): 2203634, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128723
15.
Vaccine value profile for Chikungunya.
Vaccine
; 2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38407992
16.
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.
EClinicalMedicine
; 64: 102140, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37711219
17.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
Vaccine
; 40(35): 5263-5274, 2022 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715351
18.
Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal.
Hum Vaccin Immunother
; 18(5): 2051413, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353657
19.
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age.
Lancet Reg Health West Pac
; 24: 100484, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35664443
20.
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
NPJ Vaccines
; 7(1): 12, 2022 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087084